• SENSEX 71,909.70
    -570.59 (--0.79%)
  • BANKNIFTY 54,450.75
    -182.30 (--0.33%)
  • ICICI Bank
    1,305.50 1,187.55(%)
  • NSE
    1,735.10 1,735.10(%)
  • Moneyview
    62.00 62.00(%)
  • HDFC Bank
    721.45 1,020.35(%)
  • Reliance Industries
    1,161.00 1,161.00(%)
  • Bharti Airtel
    1,726.05 1,726.05(%)
  • Kotak Mah. Bank
    435.55 452.98(%)
  • Infosys
    1,035.00 1,727.85(%)
  • Eternal
    309.80 212.55(%)
  • Molbio Diagnosti
    1,569.80 1,686.50(%)
  • SBI
    945.55 857.30(%)
  • Hero Motors
    167.80 167.80(%)
  • PB Fintech.
    965.00 965.00(%)
  • M & M
    2,812.60 2,812.60(%)
  • T R I L
    298.70 501.25(%)
  • Cupid
    314.40 314.40(%)
  • Ather Energy
    1,372.85 566.00(%)
  • Bank of Baroda
    234.00 325.55(%)
  • A-One Steels
    469.45 469.45(%)
  • Maruti Suzuki
    11,304.30 11,304.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dipna Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77240.0
  • ISIN : INE0MC401013
4.15 0 (-4.82%)
  • As on 01 Oct 2026 (EOD)

  • Today’s Low

    4.15

  • Today’s High

    4.35

  • Open

    4.25

  • Perv Close

    4.36

  • 52W Low

    3.90

  • 52W High

    25.00

Key Indicators

  • P/E(TTM)

    4.15

  • Mar.Cap (₹Cr.)

    10.91

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.70

  • Debt-Equity Ratio

    -4.82

  • AGM Date

    01-Oct-2026

  • EPS

    1.00

  • P/E Ratio

    4.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    10.91

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    26.29

  • BV (₹)

    23.70

  • Sales( ₹ in Cr.)

    129.08

  • NP (in Cr.)

    2.63

  • NP Var(%)

    170.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    10.91

  • 52 Week High

    25.00

  • 52 Week Low

    3.90

  • Price BSE

    4.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.91

  • P/C Ratio

    4.00

  • P/E Ratio

    4.00

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 124.92 164.34 99.93 72.76 31.00 30.54
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 124.92 164.34 99.93 72.76 31.00 30.54
Other Income 0.01 0.00 0.01 0.01 0.02 0.01
Stock Adjustments -9.95 18.44 12.64 -0.89 1.64 2.22
Total Income 114.98 182.78 112.58 71.88 32.66 32.77
EXPENDITURE :            
Raw Materials 103.78 176.35 108.13 67.67 31.22 31.16
Power and Fuel Cost 0.01 0.01 0.00 0.00 0.00 0.00
Employee Cost 0.41 0.44 0.00 0.00 0.41 0.38
Other Manufacturing Expenses 0.08 0.07 0.11 0.31 0.04 0.03
Selling and Administration Expenses 6.90 2.35 1.92 1.66 0.54 0.61
Miscellaneous Expenses 0.05 0.12 0.05 0.05 0.03 0.11
Employee Benefit Expenses 0.41 0.44 0.00 0.00 0.41 0.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.23 179.33 110.21 69.69 32.24 32.30
Operating Profit 3.75 3.45 2.36 2.19 0.41 0.46
Interest 2.32 2.01 0.97 0.61 0.35 0.39
Gross Profit 1.43 1.44 1.39 1.58 0.06 0.07
Depreciation 0.01 0.02 0.01 0.01 0.01 0.01
Profit Before Tax 1.42 1.42 1.38 1.57 0.05 0.06
Current Tax 0.45 0.34 0.47 0.41 0.03 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.97 1.09 0.91 1.17 0.02 0.06
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.97 1.09 0.91 1.17 0.02 0.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2.15 1.06 1.48 0.31 0.29 0.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 1.33 0.00 0.00 0.00
P & L Balance carried down 3.12 2.15 1.06 1.48 0.31 0.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.41 0.45 0.76 333.39 6.91 16.86
Earnings Per Share(Adj)-Unit Curr 0.41 0.45 0.62 - - -
Book Value 16.01 15.60 20.35 496.73 163.34 156.43
Book Value(Adj)-Unit Curr 16.01 15.60 16.72 - - -

Shareholding Pattern

  • Promoter Group

    9.13%

  • Public Share Holding

    90.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,399,700 9.13 2,399,700 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,399,700 9.13 2,399,700 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 235,000 0.89 235,000 11
Clearing Members 4,250 0.02 4,250 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 789,250 3.00 789,250 29
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,523,000 5.79 1,523,000 93
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 15,282,710 58.13 15,282,710 119
Individuals holding nominal share capital up to Rs. 1 lakh 6,055,340 23.03 6,055,340 1,530
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 23,889,550 90.87 23,889,550 1,784
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 26,289,250 100.00 26,289,250 1,788

Company Background

Dipna Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dipna Pharmachem Ltd
  • BSE Code : 77240.0
  • ISIN : INE0MC401013

  • Incorporation Year

    2011

  • Registered Office

    A/211 Siddhi Vinayak Complex
    Near D A V School Makarba, Ahmedabad,
    Gujarat-380055

  • Telephone

    91-079-9898066121

  • FAX

  • Chairman

  • Managing Director

    Keyur Shah

  • Company Secretary

  • Auditor

    Devadiya & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Dipna Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dipna Pharmachem 4.15 124.93 124.92 4.15 6.64
Abbott India 26,832.10 7,217.19 6,929.05 35.31 43.78
Astrazeneca Phar 6,030.45 2,304.07 2,275.58 88.88 27.86
Glaxosmi. Pharma 2,774.50 3,932.76 3,790.20 44.32 58.17
Novartis India 1,967.85 393.10 354.33 49.69 15.94
Cipla 1,346.85 20,102.60 18,979.95 35.40 13.88
Bliss GVS Pharma 684.20 773.53 729.81 63.59 12.51
Fermenta Biotec. 551.35 474.15 450.25 25.74 18.77
Amrutanjan Healt 513.80 520.13 502.55 27.52 24.16
Guj. Themis Bio. 382.35 168.25 165.82 102.23 18.05
Ambalal Sarabhai 37.92 19.52 3.94 70.22 6.77